Table 2.
Total cholesterol | ||||
---|---|---|---|---|
Group | M | A | ϕ | P (H0: A = 0) |
A | 170.4 | 24.8 | –244 | <0.001 |
B | 170.2 | 21.5 | –267 | <0.001 |
C | 166.9 | 16.4 | –245 | <0.001 |
D | 165.5 | 22.7 | –221 | <0.001 |
Tests of equality of parameters among groups: F (P) | (A–ϕ) | |||
All 4 groups | 1.797 (0.150) | 8.331 (< 0.001) | 18.611 (< 0.001) | 12.790 (< 0.001) |
B versus A | 0.009 (0.926) | 4.503 (0.036) | 20.706 (< 0.001) | 10.697 (< 0.001) |
C versus B | 2.239 (0.138) | 9.941 (0.002) | 8.920 (0.004) | 10.335 (< 0.001) |
D versus C | 0.519 (0.474) | 10.467 (0.002) | 10.257 (0.002) | 7.406 (0.001) |
D versus A | 2.937 (0.091) | 1.358 (0.248) | 13.831 (< 0.001) | 8.268 (< 0.001) |
High-density lipoprotein cholesterol | ||||
---|---|---|---|---|
Group | M | A | ϕ | P (H0: A = 0) |
A | 41.6 | 12.6 | –242 | <0.001 |
B | 47.9 | 13.1 | –253 | <0.001 |
C | 46.3 | 13.6 | –245 | <0.001 |
D | 38.7 | 10.4 | –221 | <0.001 |
Tests of equality of parameters among groups: F (P) | (A–ϕ) | |||
All 4 groups | 30.616 (< 0.001) | 2.928 (0.036) | 7.341 (< 0.001) | 8.583 (< 0.001) |
B versus A | 44.502 (< 0.001) | 0.365 (0.547) | 4.350 (0.040) | 3.163 (0.044) |
C versus B | 2.731 (0.102) | 0.380 (0.539) | 2.362 (0.128) | 1.166 (0.314) |
D versus C | 39.561 (< 0.001) | 6.564 (0.013) | 13.400 (0.001) | 15.082 (< 0.001) |
D versus A | 5.688 (0.020) | 3.250 (0.076) | 8.993 (0.004) | 8.379 (< 0.001) |
Phospholipids | ||||
---|---|---|---|---|
Group | M | A | ϕ | P (H0: A = 0) |
A | 103.8 | 22.5 | –226 | <0.001 |
B | 126.6 | 25.5 | –216 | <0.001 |
C | 125.7 | 27.1 | –232 | <0.001 |
D | 120.6 | 8.7 | –298 | 0.016 |
Tests of equality of parameters among groups: F (P) | (A–ϕ) | |||
All 4 groups | 41.486 (< 0.001) | 16.853 (< 0.001) | 4.067 (0.008) | 14.150 (< 0.001) |
B versus A | 116.902 (< 0.001) | 2.092 (0.151) | 1.602 (0.209) | 1.245 (0.290) |
C versus B | 0.115 (0.735) | 0.441 (0.508) | 4.410 (0.038) | 3.278 (0.040) |
D versus C | 2.874 (0.095) | 35.105 (< 0.001) | 5.527 (0.022) | 20.262 (< 0.001) |
D versus A | 45.853 (< 0.001) | 32.831 (< 0.001) | 7.831 (0.007) | 21.586 (< 0.001) |
Total lipids | ||||
---|---|---|---|---|
Group | M | A | ϕ | P (H0: A = 0) |
A | 386.0 | 75.1 | –257 | <0.001 |
B | 524.3 | 75.1 | –258 | <0.001 |
C | 505.9 | 50.5 | –242 | <0.001 |
D | 494.9 | 29.0 | –122 | 0.002 |
Tests of equality of parameters among groups: F (P) | (A–ϕ) | |||
All 4 groups | 50.049 (< 0.001) | 15.967 (<0.001) | NA | 21.348 (< 0.001) |
B versus A | 119.305 (< 0.001) | <0.001 (0.994) | 0.021 (0.886) | 0.010 (0.990) |
C versus B | 1.942 (0.167) | 11.157 (0.001) | 2.222 (0.139) | 6.383 (0.002) |
D versus C | 0.686 (0.411) | 17.543 (< 0.001) | NA | 31.106 (< 0.001) |
D versus A | 65.238 (< 0.001) | 39.953 (< 0.001) | NA | 46.594 (< 0.001) |
M MESOR, A 24-h amplitude, ϕ 24-h acrophase (360° ≡ 24 h, 0°: 00:00) NA not applicable (acrophases more than 180° apart, P < 0.05 if 95 % confidence intervals do not overlap)